PHDS HEALTHCARE RESEARCH Co., Ltd.
Senior executives of BoShiZhiXing attended the 1st World Conference on Medicinal Chemistry in 2010
Release time:
2010-05-18
Senior executives from BoShiZhiXing attended the 1st World Drug Chemistry Conference in 2010, listening to and participating in speeches by the most influential pharmaceutical chemistry experts from around the world.
The conference was held from May 18 to 20, 2010, at the China National Convention Center in Beijing. This meeting invited the most influential experts in the field of drug chemistry research to lead the presentations, with 100 executives, senior scientists, and project leaders from world-renowned universities, research institutions, and top 500 pharmaceutical companies delivering technical reports, conveying the latest development trends and cutting-edge directions in international drug chemistry technology to the world. The conference included 1 plenary session and 20 thematic discussions. Topics included: the latest breakthrough advancements in drug chemistry; fragment-based drug discovery; target molecule design for DNA/RNA; biological processes and green chemistry in drug synthesis during the preclinical phase; bioinformatics and computer-aided drug design; pharmaceutical chemistry research on anticancer drugs, anti-infective disease drugs, neurodegenerative disease drugs, and drugs for diabetes and obesity; high-throughput screening for the separation of natural medicines in traditional Chinese medicine; and trends in outsourcing alliances for pharmaceutical chemistry research and development.

Keyword:
Previous article
Relevant regulations and policies
Key points and judgment principles for the quality management of non-clinical research of drugs
In order to standardize the on-site inspection work of Good Laboratory Practice (GLP) for non-clinical drug research and improve inspection quality, the "Key Points and Determination Principles for the Inspection of Good Laboratory Practice in Non-Clinical Drug Research" has been formulated in accordance with relevant requirements such as the "Drug Administration Law of the People's Republic of China," "Good Laboratory Practice for Non-Clinical Drug Research," and "Management Measures for the Certification of Good Laboratory Practice for Non-Clinical Drug Research."
2024-11-22
Technical requirements for the latest declaration data electronic disc
In order to further improve the quality and efficiency of the preparation of electronic application materials for drug registration, and to standardize the management of electronic application materials, our center has updated the "Technical Requirements for Electronic Discs of Application Materials" and "Structure of Electronic Documents for Drug Registration Applications" published on December 2, 2022, based on feedback.
2024-11-22
In December 2023, PHDS HEALTHCARE RESEARCH Co., Ltd. was elected as the vice president unit of the China Food and Drug Enterprise Quality Safety Promotion Association, as well as the vice chairman of its subordinate digital professional committee (Certificate No.: Zhong Shi Yao An Cu Hui Zheng Zi 798). The election and award ceremony took place at the Three Gorges Hospital of Chongqing Medical University.
2024-11-22
On March 26-27, 2024, the China Wuxi Global Oral Forum and the China Food and Drug Promotion Association High-Quality Development Conference, guided by the Wuxi Municipal People's Government and the Wuxi Council for the Promotion of International Trade, and organized by the China Food and Drug Promotion Association and the Oral Health Committee of the China Food and Drug Promotion Association, will be grandly held at the Wuxi International Conference Center.
2024-11-22

京公网安备11010502056452号